Xipere Injection, Suspension
Product Images NDC 24208-040
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Xipere (NDC 24208-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Step 1 (Xipere 02)
Step 2 (Xipere 03)
Step 3 (Xipere 04)
Step 4 (Xipere 05)
Step 5 (Xipere 06)
Step 6 (Xipere 07)
Step 7 (Xipere 08)
Step 8 (Xipere 09)
Step 9 (Xipere 10)
Step 10 (Xipere 11)
Step 11 (Xipere 12)
Step 12 (Xipere 13)
Step 13 (Xipere 14)
Step 14 (Xipere 15)
Step 15 (Xipere 16)
Step 16 (Xipere 17)
Chemical Structure (Xipere 18)
Figure 1 (Xipere 19)
Figure 2 (Xipere 20)
Carton (Xipere 23)
XIPERE is a medication that contains triamcinolone acetonide injectable suspension, with a concentration of 40 mg/mL. It is intended for suprachoroidal use only and comes in a carton that contains a single-dose glass vial of medication, an SCS Microinjector syringe with vial adapter attached, two needles, and a package insert. It should be stored at a temperature between 15°C to 25°C, should be protected from light, and should not be frozen.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.